Noble James

Director at ADAPY; Director at GW PHARMACEUTICALS PLC

Sold, on record
$7.3M
Dollars the filings state
Form 4 sales
3
Latest May 29, 2020
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
3
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale GW PHARMACEUTICALS PLCUnusual
    May 24, 2019 2019

    Sold 82,596 shares at $15.32 ($1.3M)

    Noble James, Director

    Sold 75% of holdings ($1.7M position)27,500 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ADAPYUnusual
    Jan 13, 2020 +234 days

    Sold 300,000 shares at $4.67 ($1.4M)

    Noble James, Director

    Sold 100% of holdings ($1.4M position)0 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale ADAPYUnusual
    May 29, 2020 +137 days

    Sold 500,000 shares at $9.33 ($4.7M)

    Noble James, Director

    Sold 100% of holdings ($4.7M position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Noble James
Source
May 29, 2020Jun 2, 2020ADAPYDirectorForm 4 sale500,000$4.7M100.0%UnusualSEC
Jan 13, 2020Jan 15, 2020ADAPYDirectorForm 4 sale300,000$1.4M100.0%UnusualSEC
May 24, 2019May 29, 2019GW PHARMACEUTICALS PLCDirectorForm 4 sale82,596$1.3M75.0%UnusualSEC